Facilitating pandemic preparedness in the Asia Pacific through technology transfer initiatives

Vaccines |  Influencers | 7 Comment | 27 Jun, 2022

Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious dise...Read more

Australia calls for urgent review on vaccines during pregnancy

Vaccines |  News | 0 Comment | 20 Jun, 2022

Australia's University of Queensland (UQ) researchers are calling for an urgent review of low influenza vaccination rate...Read more

Takeda's dengue vaccine proves protection through 4.5 yrs of clinical trials

Vaccines |  News | 0 Comment | 15 Jun, 2022

Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...Read more

Korea expands typhoid conjugate vaccine delivery options in public health programmes

Vaccines |  News | 0 Comment | 15 Jun, 2022

A new study jointly conducted by South Korea-based International Vaccine Institute (IVI) and collaborators shows multido...Read more

China's SINOVAC polio vaccine receives WHO prequalification

Vaccines |  News | 0 Comment | 10 Jun, 2022

SINOVAC Biotech, a leading provider of biopharmaceutical products in China, has received the World Health Organization (...Read more

Japan's Daiichi Sankyo to commercialise mRNA vaccine against COVID-19 in 2022

Vaccines |  News | 0 Comment | 03 Jun, 2022

Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...Read more

Moderna to become marketing authorization holder in Japan for Spikevax COVID-19 Vaccine

Vaccines |  News | 0 Comment | 02 Jun, 2022

Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...Read more

Korea, Ethiopia establish collaborating centre for joint vaccine research

Vaccines |  News | 0 Comment | 25 May, 2022

South Korea-based International Vaccine Institute (IVI) and Armauer Hansen Research Institute (AHRI), established by the...Read more

New Zealand announces funding worth $40.7 M for development of novel mRNA vaccines, therapies

Vaccines |  News | 0 Comment | 24 May, 2022

The University of Auckland in New Zealand has received budget funding of $40.7 million for development of novel mRNA vac...Read more

WHO validates China's Convidecia as 11th vaccine for COVID-19

Vaccines |  News | 0 Comment | 20 May, 2022

The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...Read more

Korea expands collaboration in vaccine development, delivery & training

Vaccines |  News | 0 Comment | 17 May, 2022

The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea (ROK),...Read more

SK bioscience acquires approval for typhoid conjugate vaccine

Vaccines |  News | 0 Comment | 17 May, 2022

South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...Read more

India-Australia collaboration to develop ‘variant-proof’ COVID-19 vaccine

Vaccines |  News | 0 Comment | 10 May, 2022

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...Read more

China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV

Vaccines |  News | 0 Comment | 05 May, 2022

Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...Read more

Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China

Vaccines |  News | 0 Comment | 03 May, 2022

Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...Read more

SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine

Vaccines |  News | 0 Comment | 02 May, 2022

South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more

Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines

Vaccines |  News | 0 Comment | 28 Apr, 2022

GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more

Sanofi gears to leverage Evolutive Vaccine Facility (EVF) in Asia by 2025

Vaccines |  News | 0 Comment | 20 Apr, 2022

On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...Read more